• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | Inspections
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NamePARADIGM REAL-TIME SYSTEM AND GUARDIAN REAL-TIME SYSTEM
Classification Namesensor, glucose, invasive
Generic Namecontinuous subcutaneous glucose monitoring system
ApplicantMEDTRONIC MINIMED
PMA NumberP980022
Supplement NumberS021
Date Received10/30/2007
Decision Date04/18/2008
Product Code
MDS[ Registered Establishments with MDS ]
Advisory Committee Clinical Chemistry
Supplement Typenormal 180 day track
Supplement Reason change design/components/specifications - other
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for an optional capability of automatically downloading glucose results from the lifescan onetouch ultralink blood glucose meter in addition to the current bd paradigm link glucose meter. This modification includes an optional capability for the minimed paradigm real-time insulin infusion pumps or the guardian real-time glucose monitor to receive blood glucose values automatically transmitted by a lifescan onetouch ultralink blood glucose meter. The guardian? real-time system is indicated for continuous or periodic monitoring of glucose levels in the fluid under the skin, in children and adults, ages 7 and up, with diabetes mellitus, for the purpose of improving diabetes management. It alerts if a glucose level falls below, or rises above, preset values. Values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a home glucose monitor. The system provides real-time glucose values that allow users to track patterns in glucose concentrations and to possibly identify episodes of low and high blood glucose. It also stores the data so that it can be analyzed to track patterns. Glucose data can be further downloaded to pc software for analysis of historical glucose values. The guardian real-time monitor can be programmed to receive fingerstick blood glucose calibration values transmitted from the bd paradigm link or lifescan onetouch ultralink glucose meters. Calibration values from other glucose meters must be manually entered into the monitor. The paradigm? real-time system is indicated for continuous or periodic monitoring of glucose levels in the fluid under the skin, and possible low and high blood glucose episodes in children and adults, ages 7 and up. (see approval order for additional info).
-
-